Digital system to improve postoperative care for colorectal cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, prospective interventional study enrolling 236 adults who underwent colorectal cancer surgery and following them for 52 weeks. The trial uses a digital health management platform that integrates AI-driven symptom analysis and alerts to guide post-treatment care. Participants report symptoms and health data online, and the system tracks adherence, satisfaction, quality of life, and healthcare utilization to identify opportunities for improvement. Primary outcome is the 3-month follow-up rate, with multiple secondary endpoints including longer-term follow-up, medication adherence, alert metrics, quality of life, usability, and clinical outcomes such as progression-free and overall survival. The study aims to show that the digital platform improves follow-up adherence, reduces unplanned visits, and increases patient satisfaction.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Over 18 years old.
* Pathologically confirmed colorectal cancer patients.
* Underwent surgery at the Colorectal Cancer Diagnosis and Treatment Center, Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine.
* Signed informed consent form.

Exclusion Criteria:

* Unable to access electronic devices that can connect to the internet or mobile communications.
* Uncontrolled psychiatric illness.
* The ECOG score is greater than or equal to 3.
* Deemed unsuitable for participation by the investigator.

Where it's running

• Shanghai Jiao Tong University School of Medicine, Renji Hospital
  Shanghai, China Recruiting

Study contacts

• Principal investigator: Jun Qin — RenJi Hospital
• Study coordinator: Xiaomiao Wang
• Email: wangxm0109@163.com
• Phone: +8617843321256

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exercise after pelvic radiation to see if it lowers colorectal cancer risk

  This study tests whether regular walking therapy after pelvic radiation for prostate cancer can influence markers of colorectal cancer in colon tissue and blood.

  Recruiting at 2 sites City of Hope Medical Center · Duarte, California and 1 other locations · NCT07790718

• Irreversible Electroporation for Recurrent Pelvic Tumors

  This study tests whether using irreversible electroporation (IRE) is safe and helps control recurrent pelvic tumors in adults who can’t have other local treatments.

  Recruiting Amsterdam UMC, location VUmc · Amsterdam, North Holland · NCT07782164

• Smart Symptom Tracking with ALEX for GI Health in Young Adults

  This trial tests whether the Smart Symptom Tracking ALEX app can better track GI symptoms in young adults (18–44) compared with standard paper logs.

  Recruiting Mayo Clinic · Jacksonville, Florida · NCT07618273

• Culturally adapted online genetic counseling and testing education for African American cancer survivors

  We will test a culturally adapted online genetic counseling program to see if it increases genetic counseling and genetic testing among African American breast, prostate, and colorectal cancer survivors.

  Recruiting Barbara Ann Karmanos Cancer Institute · Detroit, Michigan · NCT07436078

• Zanidatamab given before surgery for HER2-positive colon or rectal cancer

  This tests whether giving zanidatamab before surgery helps adults with HER2-positive, RAS‑wildtype colon or rectal cancer who are planned for curative treatment.

  Recruiting at 4 sites Phase 2 Emory University · Atlanta, Georgia and 3 other locations · NCT07405476

• In-home cancer treatment with remote specialist support for patients in the Florida Panhandle

  This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.

  Recruiting Phase 2 Mayo Clinic · Jacksonville, Florida · NCT07285044

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.